Addressing a weakness of anticancer therapy with mitosis inhibitors: Mitotic slippage
Mitosis inhibitors, which include antimicrotubule drugs, are chemotherapy agents that induce the arrest and apoptosis of mitotic cells. Mitotic slippage, in which mitotically arrested cells exit mitosis, limits the effectiveness of mitosis inhibitors. We have discovered that the CRL2ZYG11A/B ubiquit...
Main Authors: | Riju S. Balachandran, Edward T. Kipreos |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-03-01
|
Series: | Molecular & Cellular Oncology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/23723556.2016.1277293 |
Similar Items
-
Generation of an induced pluripotent stem cell line (MUSIi014-A) from an affected member of a family with autosomal dominant diabetes carrying p.L475P mutation in ZYG11A gene associated with a cell cycle arrest in beta-cell
by: Chutima Chanprasert, et al.
Published: (2022-04-01) -
Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
by: Oakley C. Olson, et al.
Published: (2017-04-01) -
Generation of an induced pluripotent stem cell line (MUSIi015-A) from a diabetic patient carrying mutations in ZYG11A (p.L475P) and GATA6 (p.E51K)
by: Siriwal Suwanpitak, et al.
Published: (2022-08-01) -
The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and Therapy
by: Christine Greil, et al.
Published: (2022-06-01) -
APC/C-Cdh1-dependent anaphase and telophase progression during mitotic slippage
by: Toda Kazuhiro, et al.
Published: (2012-02-01)